Microbiome analysis is still a very academically heavy innovation area, exhibiting nearly a 14:1 ratio of papers to patents in 2018. This highlights that commercialization is in its infancy and clients need to prioritize high-density regions of leading research organizations like the U.S. when choosing "where" to focus microbiome innovation efforts. Nestlé has selected one of those leading organizations from the U.S. by partnering with the University of California, San Diego (UCSD), and it is not the first to do so. It is imperative that clients follow suit, whether that be partnering with UCSD or another leading university, especially as evidence mounts on the relationship between the gut microbiome, nutrition, and disease.
For the original news article,